Home blood metabolite monitor for at-home health management
Official title: Whole Blood Point of Care Metabolic Measurement - SB1
Funded at Sequitur Health Corp. · NIH-11415774 · Data updated 2026-11-12
A home device to reliably measure a specific blood metabolite that can trigger metabolic crises, helping patients, caregivers, and doctors manage health from home.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sequitur Health Corp. NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,000,001 |
| NIH project number | 5SB1HD116629-03 |
| Project ID | NIH-11415774 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are patients with certain metabolic disorders who are at risk of metabolic crises and their caregivers who would use the home device.
✕Less likely to help
Patients without metabolic disorders or those not requiring home monitoring may not benefit from this device.
What this research studies
This grant supports completing late-stage development and preparing for commercialization of a personal device that measures a key blood metabolite from a single drop of blood. It focuses on software, hardware, and regulatory strategies to bring the device to market for patients with metabolic disorders. The project builds on prior NIH and NSF work to ensure the device is accurate, user-friendly, and safe for home use by patients of all ages and their caregivers. If successful, it could enable better control of metabolic crises and improve health outcomes in everyday life.
Why it matters
Potential benefit: If successful, the device could enable earlier detection and better management of metabolic crises at home, reducing emergency visits and improving quality of life.
How similar studies have gone: Previous phase II work demonstrated accurate measurement from a single drop of blood, supporting progression to late-stage development.
Where this research is happening
-
Sequitur Health Corp.
Scottsdale, United States Active
Researchers
- Principal investigator: Thomas, Marylaura Lind — Sequitur Health Corp.
- Study coordinator: Thomas, Marylaura Lind
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.